ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05205	Proteoglycans in cancer	21/202	271/7206	2.08104460665e-05
ko05200	Pathways in cancer	31/202	492/7206	2.31763012281e-05
ko04390	Hippo signaling pathway	16/202	188/7206	6.91787337748e-05
ko04670	Leukocyte transendothelial migration	14/202	151/7206	7.91225116179e-05
ko05217	Basal cell carcinoma	9/202	68/7206	0.00010517489863
ko05160	Hepatitis C	13/202	153/7206	0.000340758738602
ko05224	Breast cancer	14/202	174/7206	0.000355438534492
ko05100	Bacterial invasion of epithelial cells	10/202	99/7206	0.000425538902522
ko04666	Fc gamma R-mediated phagocytosis	11/202	122/7206	0.000591058471251
ko04916	Melanogenesis	12/202	142/7206	0.000604666112632
ko04011	MAPK signaling pathway - yeast	7/202	53/7206	0.000632593791569
ko04530	Tight junction	16/202	228/7206	0.000634337661072
ko00512	Mucin type O-glycan biosynthesis	5/202	29/7206	0.00113008617149
ko04370	VEGF signaling pathway	8/202	77/7206	0.00132988121401
ko05206	MicroRNAs in cancer	13/202	177/7206	0.00135163654502
ko04392	Hippo signaling pathway -multiple species	5/202	31/7206	0.00154505204308
ko05131	Shigellosis	8/202	82/7206	0.00199948233869
ko04611	Platelet activation	12/202	163/7206	0.00201701641027
ko04550	Signaling pathways regulating pluripotency of stem cells	12/202	165/7206	0.00223509576328
ko00590	Arachidonic acid metabolism	6/202	52/7206	0.00313210602105
ko04514	Cell adhesion molecules (CAMs)	10/202	130/7206	0.00343478256689
ko00511	Other glycan degradation	4/202	26/7206	0.0055220655491
ko04668	TNF signaling pathway	9/202	120/7206	0.00638594730141
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	7/202	79/7206	0.00645225448681
ko04750	Inflammatory mediator regulation of TRP channels	9/202	122/7206	0.00710097221537
ko04144	Endocytosis	18/202	342/7206	0.0103137497232
ko04722	Neurotrophin signaling pathway	10/202	160/7206	0.0142475415538
ko04726	Serotonergic synapse	9/202	137/7206	0.0145869747537
ko04658	Th1 and Th2 cell differentiation	7/202	96/7206	0.0178482082509
ko05132	Salmonella infection	7/202	98/7206	0.0197762908007
ko04810	Regulation of actin cytoskeleton	14/202	264/7206	0.0203725310672
ko05130	Pathogenic Escherichia coli infection	6/202	77/7206	0.0205362439995
ko00564	Glycerophospholipid metabolism	7/202	99/7206	0.0207930265985
ko05146	Amoebiasis	7/202	99/7206	0.0207930265985
ko04912	GnRH signaling pathway	8/202	122/7206	0.0209682928391
ko04660	T cell receptor signaling pathway	8/202	124/7206	0.0228741922388
ko01522	Endocrine resistance	8/202	124/7206	0.0228741922388
ko00540	Lipopolysaccharide biosynthesis	1/202	1/7206	0.0280321953928
ko04330	Notch signaling pathway	5/202	62/7206	0.0293269028779
ko00600	Sphingolipid metabolism	5/202	63/7206	0.0311559058902
ko04012	ErbB signaling pathway	7/202	109/7206	0.0330225187252
ko04657	IL-17 signaling pathway	6/202	87/7206	0.0348421158139
ko00460	Cyanoamino acid metabolism	2/202	11/7206	0.0364110309467
ko04015	Rap1 signaling pathway	14/202	278/7206	0.0378867274567
ko04360	Axon guidance	12/202	233/7206	0.0399032067255
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	3/202	28/7206	0.0425034865946